Evidence
Expert Opin Ther Targets. 2023 Jun 19. doi: 10.1080/14728222.2023.2225216. Online ahead of print.
ABSTRACT
BACKGROUND: Major depressive disorder is a mental health disorder that is characterized by a persistently low mood and loss of interest. MDD is affecting over 3.8% of the global population as a major health problem. Its etiology is complex, and involves the interaction between a number of factors, including genetic predisposition and the presence of environmental stresses.
AREAS COVERED: The role of the immune and inflammatory systems in depression has been gaining interest, and evidence suggesting the potential involvement of pro-inflammatory molecules like TNF, interleukins, prostaglandins, and other cytokines, among others, has been put forth. Along with this, the potential of agents, from NSAIDs to antibiotics are being evaluated in the therapy of depression. The current review will discuss emerging immune targets at the preclinical level.
EXPERT OPINION: With increasing evidence to show that immune and inflammatory mediators are implicated in MDD, increasing research toward their potential as drug targets is encouraged. At the same time, agents acting on these mediators and possessing anti-inflammatory potential are also being evaluated as future therapeutic options for MDD, and increasing focus toward non-conventional drugs which can act through these mechanisms is important as regards the future prospects of the use of anti-inflammatory agents in depression.
PMID:37334668 | DOI:10.1080/14728222.2023.2225216
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Major depressive disorder (mdd): emerging immune targets at preclinical level
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Inflammatory mediators in major depression and bipolar disorder
- Decoding the inflammatory signature of the major depressive episode: insights from peripheral immunophenotyping in active and remitted condition, a case-control study
- Alzheimer Disease-Link With Major Depressive Disorder and Efficacy of Antidepressants in Modifying its Trajectory
- Inflammation and immune system pathways as biological signatures of adolescent depression-the IDEA-RiSCo study
- Causal role of immune cells in major depressive disorder and bipolar disorder: Mendelian randomization (MR) study
- Mediation of social anxiety and depression during internet-delivered treatment for social anxiety disorder
- Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications
- AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort
- The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder
- The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder
- Pro- and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases)
- Global, regional, and national temporal trend in burden of major depressive disorder from 1990 to 2019: An analysis of the global burden of disease study
- Elevated SCN11A concentrations associated with lower serum lipid levels in patients with major depressive disorder
- T cell activation and deficits in T regulatory cells are associated with major depressive disorder and severity of depression
- The Association of Redox Regulatory Drug Target Genes with Psychiatric Disorders: A Mendelian Randomization Study
- Shared genetic effect of kidney function on bipolar and major depressive disorders: a large-scale genome-wide cross-trait analysis
- Altered effective connectivity among face-processing systems in major depressive disorder
- Gut microbiota and inflammatory factor characteristics in major depressive disorder patients with anorexia
- Association between peripheral plasma cytokine levels and suicidal ideation in first-episode, drug-naive major depressive disorder
- Diagnostic conversion to bipolar disorder among adolescents and young adults with major depressive disorder: a nationwide longitudinal study
- The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder
- The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder
- The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder
- Innova4Health: an integrated approach for prevention of recurrence and personalized treatment of Major Depressive Disorder
- Innova4Health: an integrated approach for prevention of recurrence and personalized treatment of Major Depressive Disorder
- The metabolome-wide signature of major depressive disorder
- Cerebral malaria pathogenesis: Dissecting the role of CD4+ and CD8+ T-cells as major effectors in disease pathology
- Ketamine's mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine's antidepressant effects?
- Comparing Symptoms of Major Depression in Youth with Confirmed Versus Suspected Bipolar Disorder
- Interaction between HTR2A rs3125 and negative life events in suicide attempts among patients with major depressive disorder: a cross-sectional study
- A genome-wide association study of escitalopram treatment outcomes in patients with major depressive disorder
- The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease
- The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management
- Complex posttraumatic stress disorder and dissociation in trauma-exposed Chinese adolescents: a latent class analysis
- Social determinants of mental health in major depressive disorder: Umbrella review of 26 meta-analyses and systematic reviews
- Clinical distinctions in symptomatology and psychiatric comorbidities between misdiagnosed bipolar I and bipolar II disorder versus major depressive disorder
- An association study of m6A methylation with major depressive disorder
- The long-term spatio-temporal trends in burden and attributable risk factors of major depressive disorder at global, regional and national levels during 1990-2019: a systematic analysis for GBD 2019
- Relationship of Major Depressive Disorder and Schizophrenia Polygenic Risk Scores to Suicide: A Comparison Between European and Asian Ancestry Populations
- Relationship of Major Depressive Disorder and Schizophrenia Polygenic Risk Scores to Suicide: A Comparison Between European and Asian Ancestry Populations
- Novel therapeutics to treat chronic pancreatitis: targeting pancreatic stellate cells and macrophages
- Cortical activation for adolescent-onset minor depression and major depressive disorder: an fNIRS study
- Cortical activation for adolescent-onset minor depression and major depressive disorder: an fNIRS study
- The role of KCNQ channel activators in management of major depressive disorder
- Human olfactory neural progenitor cells reveal differences in IL-6, IL-8, thrombospondin-1, and MCP-1 in major depression disorder and borderline personality disorder
- Exploring the Effects of Major Depressive Disorder on Daily Occupations and the Impact of Psychotherapy: A Literature Review
- Defining "High Recurrence" of Depressive Episodes for Predicting Diagnostic Conversion from Major Depressive Disorder to Bipolar Disorder: A 5-year Retrospective Study
- The influence of gender-specific factors influencing severe anxiety in psychotic major depression: role of thyroid hormones and depression severity
- Clinical distinctions in symptomatology and psychiatric comorbidities between misdiagnosed bipolar I and bipolar II disorder versus major depressive disorder
- Prevalence and factors associated with dyslipidemia in patients with first hospitalization for major depressive disorder: a large sample cross-sectional study
- Cognitive Phenotype Shifts in Risk-Taking: Interplay of Non-Suicidal Self-Injury Behaviors and Intensified Depression
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour…
- Classification of Schizophrenia, Bipolar Disorder and Major Depressive Disorder with Comorbid Traits and Deep Learning Algorithms
- Innate Immune Dysfunction and Neuroinflammation in Autism Spectrum Disorder (ASD)
- Suicide ideation and male-female differences in major depressive disorder
- Molecular mechanism of Chang Shen Hua volatile oil modulating brain cAMP-PKA-CREB pathway to improve depression-like behavior in rats
- Genomics Research of Lifetime Depression in the Netherlands: The BIObanks Netherlands Internet Collaboration (BIONIC) Project
- The risk of Alzheimer's disease and cognitive impairment characteristics in eight mental disorders: A UK Biobank observational study and Mendelian randomization analysis
- Systems biology dissection of PTSD and MDD across brain regions, cell types, and blood
- Differences in fractional amplitude of low-frequency fluctuations (fALFF) and cognitive function between untreated major depressive disorder and schizophrenia with depressive mood patients
- Evidence for strong genetic correlations among internalizing psychopathology and related self-reported measures using both genomic and twin/adoptive approaches
- Cluster analysis dissecting cognitive deficits in older adults with major depressive disorder and the association with neurofilament light chain
- Exposure to psychotropic drugs and breast cancer risk in patients with bipolar disorder and major depressive disorder: a nested case-control study
- Global prevalence of major depressive disorder in LGBTQ+ samples: A systematic review and meta-analysis of epidemiological studies
Evidence Blueprint
Major depressive disorder (mdd): emerging immune targets at preclinical level
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Major depressive disorder (mdd): emerging immune targets at preclinical level
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Inflammatory mediators in major depression and bipolar disorder
- The Association of HHV-6 and the TNF-α (-308G/A) Promotor with Major Depressive Disorder Patients and Healthy Controls in Thailand
- Effect modification of tumor necrosis factor-α on the kynurenine and serotonin pathways in major depressive disorder on type 2 diabetes mellitus
- Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential
- Choroid plexus volume is increased in mood disorders and associates with circulating inflammatory cytokines
- Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paper
- Associations between insomnia symptoms and inflammatory cytokines in adolescents with first-episode and recurrent major depressive disorder
- Genome-wide transcriptomic and biochemical profiling of major depressive disorder: Unravelling association with susceptibility, severity, and antidepressant response
- The core inflammatory factors in patients with major depressive disorder: a network analysis
- Trace Elements Levels in Major Depressive Disorder-Evaluation of Potential Threats and Possible Therapeutic Approaches
- Decoding the inflammatory signature of the major depressive episode: insights from peripheral immunophenotyping in active and remitted condition, a case-control study
- Mediating effect of inflammation on the relationship between sleep disruption and suicidal ideation in major depressive disorder
- Elevated Plasma Levels of Mature Brain-Derived Neurotrophic Factor in Major Depressive Disorder Patients with Higher Suicidal Ideation
- Premorbid intelligence quotient and school failure as risk markers for bipolar disorder and major depressive disorder
- Dissecting the genetic overlap between severe mental disorders and markers of cellular aging: Identification of pleiotropic genes and druggable targets
- Biological markers of sex-based differences in major depressive disorder and in antidepressant response
- Lack of association between VNTR variant of the circadian gene (PER3) and major depressive disorder in a sample of a Turkish population
- Mitochondrial permeability transition pore: a snapshot of a therapeutic target
- Clarification of the molecular mechanisms underlying glyphosate-induced major depressive disorder: a network toxicology approach
- Alzheimer Disease-Link With Major Depressive Disorder and Efficacy of Antidepressants in Modifying its Trajectory
- Exploring the clinical characteristics and etiological factors of comorbid major depressive disorder and social anxiety disorder
- Plasma cytokine and growth factor response to acute psychosocial stress in major depressive disorder
- Inflammation and immune system pathways as biological signatures of adolescent depression-the IDEA-RiSCo study
- Causal role of immune cells in major depressive disorder and bipolar disorder: Mendelian randomization (MR) study
- Changes in pain during a depressive episode and relationship to cytokine levels in major depressive disorder
- Mediation of social anxiety and depression during internet-delivered treatment for social anxiety disorder
- Individual and Combined Effect of MAO-A/MAO-B Gene Variants and Adverse Childhood Experiences on the Severity of Major Depressive Disorder
- Vitamin D/Vitamin D receptor pathway in nonalcoholic fatty liver disease
- Role of T and B lymphocyte cannabinoid type 1 and 2 receptors in major depression and suicidal behaviors
- Serum levels of interleukin-33 and mesencephalic astrocyte derived neurotrophic factors in patients with major depressive disorder: a cross-sectional comparative design
- A role of splenic heme biosynthesis pathway in the persistent prophylactic actions of arketamine in lipopolysaccharide-treated mice
- Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications
- Potential therapeutic targets for Mpox: the evidence to date
- Is adjustment disorder genetically correlated with depression, anxiety, or risk-tolerant personality trait?
- AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort
- The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder
- The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder
- Proinflammatory cytokine levels, cognitive function, and suicidal symptoms of adolescents and young adults with major depressive disorder
- Differences in bacterial taxa between treatment-naive patients with major depressive disorder and non-affected controls may be related to a proinflammatory profile
- Specificity of affective dynamics of bipolar and major depressive disorder
- Major Depressive Disorder, Inflammation, and Nutrition: A Tricky Pattern?
- Association of 11 variants of the dopaminergic and cognitive pathways genes with major depression, schizophrenia and bipolar disorder in the Pakistani population
- Major depressive disorder as a moderator of the relationship between heavy-episodic drinking and anxiety symptoms
- Preexisting depression and COVID-19: a cohort study on the risk of susceptibility and hospitalization
- Preventing recurrence of postpartum depression by regulating sleep
- Explainable machine-learning algorithms to differentiate bipolar disorder from major depressive disorder using self-reported symptoms, vital signs, and blood-based markers
- Comparison of childhood trauma between depressive disorders and personality disorders
- Functional MRI correlates of emotion regulation in major depressive disorder related to depressive disease load measured over nine years
- Pro- and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases)
- Prevalence and factors associated with metabolic syndrome in first hospitalization for major depression disorder patients
- Global, regional, and national temporal trend in burden of major depressive disorder from 1990 to 2019: An analysis of the global burden of disease study
- Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management
- Cytokine profile in first-episode drug-naïve major depressive disorder patients with or without anxiety
- Elevated SCN11A concentrations associated with lower serum lipid levels in patients with major depressive disorder
- Circulating T-cell subsets discrepancy between bipolar disorder and major depressive disorder during mood episodes: A naturalistic, retrospective study of 1015 cases
- T cell activation and deficits in T regulatory cells are associated with major depressive disorder and severity of depression
- The Association of Redox Regulatory Drug Target Genes with Psychiatric Disorders: A Mendelian Randomization Study
- Shared genetic effect of kidney function on bipolar and major depressive disorders: a large-scale genome-wide cross-trait analysis
- Altered effective connectivity among face-processing systems in major depressive disorder
- Gut microbiota and inflammatory factor characteristics in major depressive disorder patients with anorexia
- Predicting diagnostic conversion from major depressive disorder to bipolar disorder: an EHR based study from Colombia
- Meta-analysis of soluble tumour necrosis factor receptors in severe mental illnesses
- Association between peripheral plasma cytokine levels and suicidal ideation in first-episode, drug-naive major depressive disorder
- Diagnostic conversion to bipolar disorder among adolescents and young adults with major depressive disorder: a nationwide longitudinal study